Stockscreener 앱 받기
527.07
1.67%
8.68
전일 마감가:
$518.39
열려 있는:
$516.57
하루 거래량:
570.11K
Relative Volume:
1.02
시가총액:
$41.52B
수익:
$4.45B
순이익/손실:
$1.10B
주가수익비율:
38.78
EPS:
13.591
순현금흐름:
$1.06B
1주 성능:
-0.38%
1개월 성능:
-1.55%
6개월 성능:
-7.46%
1년 성능:
-16.50%
1일 변동 폭
$513.48
$528.69
1주일 범위
$513.48
$536.84
52주 변동 폭
$500.61
$769.98
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, NTRA, A, ILMN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
527.07 | 40.91B | 4.45B | 1.10B | 1.06B | 13.59 |
TMO
Thermo Fisher Scientific Inc
|
676.76 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.21 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
425.64 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.29 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
ILMN
Illumina Inc
|
293.69 | 40.77B | 4.39B | 853.00M | 556.00M | 5.5097 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Neutral |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-31 | 업그레이드 | Stifel | Hold → Buy |
| 2025-10-01 | 개시 | UBS | Neutral |
| 2025-08-05 | 재확인 | BTIG Research | Buy |
| 2025-07-01 | 개시 | Jefferies | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
IDEXX Laboratories to Release 2026 Third Quarter Financial Results - 01net
IDEXX Laboratories expands parasite testing ahead of IDEXX Laboratories stock results - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) Stock Price, News, Quote & History - Yahoo! Finance Canada
IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI - marketscreener.com
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories - PR Newswire
What Does Today’s Signal Mean for IDEXX Laboratories (NASDAQ:IDXX)? - Kalkine Media
IDEXX Laboratories stock after-hours at EUR 471.50: plus 1.34 percent - AD HOC NEWS
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1% - GlobeNewswire Inc.
IDEXX Laboratories stock gained 1.14 percent on September 25 - AD HOC NEWS
IDEXX Laboratories stock falls 1.65 percent below USD 747 target - AD HOC NEWS
IDEXX Laboratories stock heads into the open after September 24 update - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) stock price, news, quote and history - Yahoo Finance Singapore
Should You Continue to Hold IDXX Stock in Your Portfolio? - TradingView
IDEXX Laboratories stock gains as revenue outlook meets premium valuation - AD HOC NEWS
IDEXX Laboratories stock heads into the open after a 1.16 percent gain - AD HOC NEWS
IDEXX Laboratories Acquires CoVetAI to Enhance Veterinary Software Ecosystem - Global Legal Chronicle
IDEXX Laboratories stock gains 1.16 percent as valuation holds - ad-hoc-news.de
IDEXX Laboratories stock heads into the open after recent gains - AD HOC NEWS
IDEXX Laboratories stock gains after double digit Q2 growth and raised guidance - AD HOC NEWS
Recent acquisitions: IDEXX buys CoVet, The Farmer's Dog acquires Woof - DVM 360
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets - Yahoo Finance
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference - Yahoo Finance
IDEXX Laboratories stock gains attention after CoVetAI deal and Stifel Buy rating - AD HOC NEWS
IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics - Yahoo Finance
IDEXX Laboratories Inc | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
IDEXX Laboratories stock holds after Stifel keeps Buy rating - AD HOC NEWS
Why Is the Market Reassessing IDEXX Laboratories (IDXX)? - Kalkine Media
IDEXX Laboratories stock holds Stifel Buy rating after Q2 earnings beat - ad-hoc-news.de
Stifel reiterates Buy on IDEXX Laboratories stock citing vet survey By Investing.com - Investing.com Australia
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide - Yahoo Finance
IDEXX Laboratories stock heads into the open after a modest pullback - AD HOC NEWS
IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus - Yahoo Finance
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence - Vet Candy
IDEXX Laboratories stock gains as CoVetAI deal and new parasite tests bolster growth narrative - AD HOC NEWS
IDEXX Stock Gains Following the Acquisition of CoVet - Yahoo Finance
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection - PA Media
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670 - Moomoo
IDEXX Laboratories (IDXX) Looks 19.8% Undervalued on GF Value™ - GuruFocus
IDEXX Laboratories Acquires Veterinary AI Software Firm CoVetAI - marketscreener.com
Press Release: IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence - Moomoo
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 38% Potential Upside For Investors - DirectorsTalk Interviews
IDXX - Finviz
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이덱스 래버러토리스 주식 (IDXX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kingsley Lawrence D | Director |
Sep 04 '26 |
Sale |
532.08 |
2,203 |
1,172,178 |
9,568 |
3.51%
자본화:
|
볼륨(24시간):